![Enno Spillner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 161 230 $ al 31/08/2026
En la actualidad, Enno Spillner ocupa el cargo de director financiero de Evotec SE y codirector general de Evotec International GmbH (una filial de Evotec SE). También forma parte del consejo de administración de Nanobiotix SA y Concentro Management AG y es socio gerente de Biom Venture Capital GmbH & Co. Fonds KG. En su anterior carrera, el Sr. Spillner ocupó el cargo de Director Ejecutivo y Financiero de 4SC AG, Director Gerente de Munich Innovative Biomaterials GmbH, Director Gerente de ActiPac Biosystems GmbH y Jefe de Finanzas y Control de BioM AG Munich BioTech Development. Enno Spillner obtuvo un MBA en la Universidad de Bamberg.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NANOBIOTIX SA 0,01 % | 31/03/2026 | 4.000 ( 0,01 % ) | 161 230 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NANOBIOTIX | Director/Miembro de la Junta | 18/06/2014 |
| FORMYCON AG | Director Financiero/CFO | 01/04/2023 |
Concentro Management AG
 Concentro Management AG Investment ManagersFinance Provides financial consulting services | Director/Miembro de la Junta | 11/05/2010 |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Director/Miembro de la Junta | - |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Director/Miembro de la Junta | 01/01/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
| EVOTEC SE | Director Financiero/CFO | 01/03/2023 |
| 4SC AG | Director Ejecutivo | 30/06/2016 |
ActiPac Biosystems GmbH | Director Ejecutivo | 01/03/2000 |
Munich Innovative Biomaterials GmbH
 Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Director Ejecutivo | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Commercial Services |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Finance |
BioM AG Munich BioTech Development
 BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities. | Finance |
University of Bamberg
 University of Bamberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biom Venture Capital GmbH & Co. Fonds KG
 Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Provides financial consulting services | Finance |
Formycon AG
 Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
ActiPac Biosystems GmbH | |
Munich Innovative Biomaterials GmbH
Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
